Skip to main content

Hologic Value Stock - Dividend - Research Selection

Hologic

ISIN: US4364401012, WKN: 879100

Market price date: 22.05.2020
Market price: 52,33 USD




Hologic Fundamental data and company key figures of the share

Annual reports in USD
Key figures 08-12-2019
Cash flow
Net operating cash flow 649.500.000
Capital Expenditures -109.100.000
Free cash flow 540.400.000
Balance sheet
Total Equity 2.279.100.000
Liabilities & Shareholders equity 6.611.100.000
Income statement
Net income -203.600.000
Eps (diluted) -0,760
Diluted shares outstanding 267.895.000
Net sales/revenue 3.367.000.000

Fundamental ratios calculated on: 22-05-2020

Ratios
Key figures 22-05-2020
Cash flow
P/C 21,58
   
P/FC 25,94
Balance sheet
ROI-3,08
ROE34,47
Income statement
P/E-68,86
Div. Yield0,00%
P/B6,15
P/S4,16


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolHOLX
Market Capitalization14.018.945.024,00 USD
CountryUnited States
IndicesNASDAQ 100,S&P 500
SectorsIndustrial goods
Raw Data SourceUS GAAP in Millionen USD
Stock Split2008-04-04,2.0000/1.0000; 2008-04-03,2.0000/1.0000; 2005-12-02,2.0000/1.0000; 2005-12-01,2.0000/1.0000; 1996-03-27,2.0000/1.0000; 1996-03-26,2.0000/1.0000
Internetwww.hologic.com


Description of the company

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health. It offers Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assay technologies, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test products. It also provides breast imaging and related products, and accessories comprising digital and film-based mammography systems; computer-aided detection for mammography; minimally invasive breast biopsy devices; breast biopsy site markers; and breast biopsy guidance systems. In addition, it offers Dimensions platform, a mammography gantry for 2D and tomosynthesis image acquisition and display; C-View and Intelligent 2D, a software product that provides 2D images; Selenia digital mammography platform; and SecurView Workstation. Further, it provides SculpSure, MonaLisa Touch, Vectus diode, and Cellulaze laser devices; PicoSure and Icon aesthetic systems; MedLite, RevLite, Cynergy, Elite, and SmartLipo products; and system components. Additionally, it offers NovaSure system to treat women suffering from abnormal uterine bleeding; MyoSure system for the hysteroscopic removal of fibroids; discovery and horizon X-ray bone densitometers that assess the bone density of fracture sites; and mini C-arm imaging systems to perform minimally invasive surgical procedures on a patient\'s extremities, such as the hand, wrist, knee, foot, and ankle. The company sells its products through direct sales and service forces, and a network of independent distributors and sales representatives. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.hologic.com